valium restless leg syndrome diazepam 5mg valium diazepam kopen

vand tramadol tramadol online pharmacy will tramadol affect blood pressure

xanax friendly doctors buy alprazolam online no prescription xanax and oxycodone interactions

can i take zanaflex with valium buy valium online reliable site to buy valium

30 milligrams ambien order ambien online my ambien isn't working

diazepam buy Baton Rouge buy valium online can you snort valium 10

cvs caremark prior authorization form ambien buy ambien online make ambien work better

can you take ambien and advil together buy ambien no prescription order ambien South Dakota

is there a drug test for soma soma medication order soma Charleston

tramadol werkt na tramadol 50mg tramadol toxicity symptoms



    Host your own Wunder Project Fundraiser

    The Wunder Project Medical Team


    Dr. Lenz

    “I am so excited about this Wunder Team because, with them, anything is possible. Together, we will change the way colon cancer is being treated in the future, and with the goal to make this cancer a disease of the past.”

    Dr. Heinz-Josef Lenz, M.D., FACP, a world-renowned oncologist, clinician, and researcher, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive Cancer Center. Dr. Lenz is ... Read More


    Dr. Kahn

    “Not everything that counts can be counted; I hope to contribute something that really counts. The Wunder Project will enable us to develop novel therapeutic agents to prevent and treat cancer and eventually eliminate cancer”

    Michael Kahn, Ph.D., is the first Provost’s Professor of Medicine and Pharmacy at the University of Southern California with a joint appointment in the Department of Biochemistry and Molecular Biology at the Keck School of Medicine and the Department ... Read More


    Dr. Laird

    “The WunderGlo Foundation is an inspiring organization built by an amazing person. I hope to contribute to this cause by figuring out how colon cancer cells turn genes on and off with molecular switches called epigenetics. We can conquer colon cancer if we can pinpoint its weaknesses and attack with precision.”

    Peter Laird, Ph.D., earned his B.S. and his M.S., Cum Laude, from the University of Leiden, the Netherlands. He received his Ph.D. from the University of Amsterdam with ... Read More


    Dr. Curtis

    “It is a privilege to be part of the Wunder Project, and to partner with others who share a common vision to transform the diagnosis and treatment of colon cancer. By exploiting state of the art approaches to systematically characterize the molecular mechanisms that drive tumor development and progression, we will develop targeted therapeutics that cripple cancer cells at their core, rendering them futile.”

    Dr. Curtis is an Assistant Professor of Preventive Medicine at the Keck ... Read More


    Dr. Casey

    “Passion comes from within. Inspiration comes from others. The Wunder Project combines both and cancer doesn’t stand a chance.”

    Graham Casey, Ph.D. is a professor of preventive medicine and co-director of the Cancer Epidemiology Program. Formerly at the Cleveland Clinic in the Department of Cancer Biology, he joined the USC Norris Comprehensive Cancer Center in 2008. Dr. Casey studies breast, prostate and colorectal cancer to understand how altered gene function, whether by ... Read More


    Dr. Tejpar

    “The Wunder Team cares about getting the results and finding out the answers, about making the progress necessary to get us to a cure for colon cancer. We want these results and answers as quickly as possible, and with The Wunder Project, we can get there.”

    After training in Internal medicine and Gastroenterology and a Ph.D. in the program of Molecular Oncology at the Center for Human Genetics, KULeuven, Prof. Tejpar became in Sept. 2003 an Associate Professor in the Dept of ... Read More


    Dr. Bardelli

    “I believe The Wunder Project has tremendous potential. The ability to integrate high profile genomic data with functional analysis of experimental models will indeed move the colorectal cancer field forward. I am thrilled to be involved in this endeavor.”

    Dr. Alberto Bardelli currently serves as the Associate Professor, Department of Oncology at the University of Torino as well as the Director, Laboratory of Molecular Genetic at The Institute for Cancer Research and Treatment, ... Read More